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ABSTRACT
Objective: This study aimed to analyze RGD-Chitosan from Shrimp Shells’ Scaffolds’ (RCSSS) and CSSS membrane toxicity toward human dental pulp 
cells.
Methods: Human dental pulp cells were cultured for 5 days and then exposed to RCSSS or CSSS membranes for 24 hrs. Cell viability was determined 
using an MTT assay method.
Results: Cell viability of the RCSSS group and CSSS group was higher than the cell viability of the control group. The cell viability of the RCSSS 
group 2 mg (537.39%) was significantly higher than the CSSS group 2 mg (301.74%).
Conclusions: RCSSS membranes were not toxic toward human dental pulp cells and showed better effect toward human dental pulp cells compared 
to CSSS membranes.
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INTRODUCTION
Bone destruction can be caused by trauma, systemic disease, congenital 
abnormalities, and pathological conditions, such as in periodontitis, 
tumors, and cysts [1]. Bone destruction generally can cause significant 
bone loss and requires surgical treatment [2]. Until now, the use of 
autograft as a bone graft is still the gold standard to repair and regenerate 
bone defects [3]. Autograft shows good biocompatibility, does not induce 
the immune reaction, and can support osteoinduction, osteoconduction, 
and osteogenesis when it is used as a bone graft. However, in its application, 
bone grafts also show several clinical issues, such as morbidity, pain, and 
hypersensitivity in the donor area, a limited number of fairly large bone 
defects, and the need for additional surgery to harvest autografts from 
the patient’s tissue [3]. These clinical issues have increased the need of 
substitute biomaterial as an alternative to bone grafts, especially in a case 
of large bone defects. One substitute is chitosan biomaterial, which can be 
used as a scaffold for bone tissue engineering [4].
Nowadays, tissue engineering is being widely studied and developed in 
hopes of better being able to regenerate tissue. The general principle 
of tissue engineering is to combine cells or vital tissues with synthetic 
supports or biomaterials that can be later transplanted to form new tissue 
or organs that functionally, structurally, or mechanically are as good as or 
even better than the original tissue [5]. One of the important components 
in tissue engineering is a scaffold. A scaffold is a three-dimensional 
structure that acts as a support for cell adhesion and deposition of an 
extracellular matrix, as well as allowing the transportation of gas, 
nutrition, and growth factors for cell proliferation and differentiation. 
Ideally, the scaffold has to be biocompatible, meaning it does not induce 
an immune reaction, is non-toxic, possesses a biodegradability property, 
and contains adequate porosity to support cell penetration [6].
One of the materials that can be used as a scaffold is chitosan. Chitosan 
derived from a material known as chitin, which is taken from shrimps 
crabs, lobsters, and other invertebrates [7]. In the past 20 years, 
chitosan has been widely studied for its scaffold potential to be used 
in tissue engineering because it possesses good biocompatibility and 
biodegradability. In addition, chitosan also has physical properties 
that enable it to be formed into a scaffold with a variety of structures, 
such as membrane, sponge, and fiber, all with adequate porosity for 
bone tissue engineering [8,9]. Based on the previous studies, chitosan 
used as a scaffold showed the capability to improve the proliferation of 
dental pulp stem cells (DPSCs) in culture. DPSCs are stem cells found in 
dental pulp and have the capability to differentiate into odontoblasts, 
osteoblasts, adipocytes, chondrocytes, myoblasts, and neural cells 
in vitro. In addition, DPSCs are also considered the appropriate 
candidate for bone formation because of its cell subpopulation, which 
has the capability to differentiate into a variety of cell types, including 
preosteoblasts in culture. It is also capable of generating bone tissue 
when transplanted in vivo [10].
As an attempt to improve its role as a scaffold, chitosan can be combined 
with other biomaterials, such as Arg-Gly-Asp (RGD) [11]. RGD is a peptide 
linked to cell adhesion and also plays a role in tissue regeneration by 
guiding cell migration [12]. RGD is commonly found in various bone 
proteins, such as fibronectin, vitronectin, fibrinogen, osteopontin, 
and bone sialoprotein [13]. Based on the previous studies, adding or 
combining RDG into a chitosan scaffold was reported to improve the 
biocompatibility of that chitosan [11,14]. Currently, the Indonesia 
National Atomic Energy Agency (BATAN) has been developing chitosan 
scaffolds from shrimp shells in the form of a membrane combined with 
RGD. However, based on the ISO standard 10993, before the scaffold 
can be transplanted or used in tissue engineering, that scaffold should 
undergo a biocompatibility test [15]. The test should be performed 
to avoid any negative effect that may arise after the scaffold comes in 
contact with body tissue. One of the tests that can be performed based 
on the ISO standard 10993 is a toxicity test in vitro. This study aimed to 
analyze RGD-chitosan from shrimp shells’ scaffolds’ (RCSSS) and CSSS 
membrane toxicity toward human dental pulp cells. All the scaffolds 
were in the form of membranes which were manufactured by the 
Indonesia National Atomic Energy Agency (BATAN). In this study, the 
cells used were human dental pulp cells that were isolated from intact 
and healthy human dental pulp extracted after orthodontic treatment.
METHODS
This study is based on experimental laboratory research conducted 
at the Laboratory of Oral Biology, Faculty of Dentistry, Universitas 
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Indonesia from July to August 2016. The test material in this study 
was RCSSS in the form of a membrane manufactured by BATAN with 
the following specifications: Degree of deacetylation 95%, molecular 
weight 75.000 Da, membrane size 2.5 cm × 1 cm, and membrane weight 
23.1 mg. Before use, each chitosan membrane was initially cut and 
weighed into 1 mg and 2 mg and then sterilized in a laminar flow (UV) 
for 10 minutes. The pilot study showed that 1 mg and 2 mg were the 
correct minimum concentrations for testing on a 96-well plate. The 
cell culture medium used in this study was the α-minimum essential 
medium solution and FBS from Gibco (USA), as well as penicillin, 
streptomycin, and amphotericin B which were produced by Sigma 
(USA). The toxicity analysis in this study was performed with the MTT 
assay method using MTT powder produced by Biomatrix (Fig. 1).
Isolation of human dental pulp
The sample in this study was human dental pulp isolated from intact 
and healthy human dental pulp extracted from orthodontic treatment. 
Human dental pulp cells were isolated following the method performed 
by Gronthos in 2000. The tooth was first cleaned, and then, crushed 
using pestle and mortar. Pulp tissue was then taken using an extirpation 
needle; then, it was cut using sterile scissors. In this study, cell isolation 
was also performed using collagenase enzyme (3 mg/ml) and dispase 
enzyme (4 mg/ml) by adding the enzyme to a tube containing the pulp 
tissue, followed by incubation for 1 hr. The obtained human dental pulp 
cells were then cultured. The cells on the third-to-fifth passages were 
used for the experiments.
Exposure to test material
Each CSSS in the form of a membrane and RCSSS in the form of a 
membrane was cut and weighed to obtain a scaffold that weighed 
1 mg and 2 mg. The scaffold membrane was then inserted into a 
microcentrifuge tube of 1.5 ml and sterilized inside a safety cabinet 
with UV exposure for 10 minutes. Human dental pulp cell (2×104) was 
cultured in a 96-well plate, with each sample in the control group, and 
the treatment group performed at least twice (two fold). The complete 
culture medium used in this study was a α-MEM culture medium 
in 50 ml medium that contained 10% FBS, 100 units/ml penicillin, 
100 µg/ml streptomycin, and 0.25 µg/ml amphotericin B. The control 
group was comprised of human dental pulp cultured in a complete 
culture medium without exposure to the test material. Meanwhile, the 
treatment group was comprised of cells exposed to CSSS in the form of a 
membrane and RCSSS in the form of a membrane 1 mg and 2 mg. Before 
being exposed to the test material, those cells were initially cultured for 
5 days to allow the cells to grow. On the 6th day, the scaffold membrane 
previously weighed was then inserted into each well of the treatment 
group. After that, the cells in the 96-well plate were incubated in a CO2 
incubator (37°C, 5% CO2) for 24 hrs, and the cell viability was analyzed 
using an MTT assay.
Viability test using MTT assay
First, some of the existing culture medium was discharged in each well. 
15 µl of MTT solution was then added into each well before the well was 
incubated in a CO2 incubator (37°C, 5% CO2) for 3 hrs. After 3 hrs, 150 µl 
of acidified isopropanol solution was added to each well, and then, the 96 
well plates were put on a shaker for 1 hr at room temperature to dissolve 
the Formazan crystals that have formed. The OD value was then read 
using an enzyme-linked immunosorbent assay (ELISA) reader at 490 nm 
wavelength, and the viability of human dental pulp cell (%) was calculated.
Data interpretation was done by comparing the viability of the human 
dental pulp cells (%) of the treatment group with the viability of the 
human dental pulp cells (%) of the control group. The experiment was 
performed twice, and in each experiment, each group was made at least 
twice (two fold).
Data analysis
The significant difference from the viability of the human dental pulp 
cells (%) of the control group and the treatment group was analyzed 
statistically using a one-way analysis of variance (ANOVA) test.
RESULTS
In this study, human dental pulp cells were cultured in a α-MEM culture 
medium that contained penicillin, streptomycin, amphotericin B, and 
FBS. Before being exposed to the test materials, the cells were cultured 
in a CO2 incubator (37°C, 5% CO2) for 5 days until the cells had grown 
sufficiently. Fig. 2 shows the human dental pulp cells on the 5th day 
at ×10 magnification.
Effect of exposure of RCSSS in the form of a membrane to the 
viability of human dental pulp cells
The effect of the exposure of RCSSS in the form of a membrane to the 
viability of the human dental pulp cells was analyzed using an MTT 
assay and OD value, or the absorbance was read using an ELISA reader 
with 490 nm wavelength. The OD value was then expressed in cell 
viability (%) toward the control cell (Fig. 3).
Fig. 1: Sample of RGD chitosan from shrimp shell scaffold in the 
form of a membrane
Fig. 2: Human dental pulp cells on the 5th day
Fig. 3: Graphic of the effect of the exposure of RGD chitosan from 
shrimp shell scaffold in the form of a membrane to the viability of 
human dental pulp cells
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The graphic shows that the cell’s viability in the treatment group 
was higher than the control group. The data normality test using 
Shapiro–Wilk test revealed that the data had a normal distribution 
(p>0.05). Based on the homogeneity test performed, the data were 
not homogeneous or identical. However, because of the same amount 
of data in each group, the homogeneity test or test for equality of the 
variances could be ignored. After the normality and homogeneity test, 
an ANOVA test was then performed to compare the mean differences 
between the five groups. Based on that test, the significance level was 
<0.05, meaning each of the five groups was different from each other.
To determine whether there was a significant difference between the 
groups being compared, a statistical analysis using one-way ANOVA with 
post hoc test (Tukey–Bonferroni) was performed. A one-way ANOVA was 
selected in this study because there were five data groups regarding cell 
viability. The one-way ANOVA test with post hoc (Tukey–Bonferroni) 
showed that there was a significant difference between the viability 
of human dental pulp cells (%) in the control group and the treatment 
group that has been exposed to 2 mg RCSSS in the form of a membrane 
(p<0.001) and the other treatment group that has been exposed to 1 mg 
CSSS in the form of a membrane (p<0.001). However, based on the test, 
even though it was revealed that the viability of human dental pulp cells 
exposed to 1 mg RCSSS in the form of a membrane and 2 mg CSSS in 
the form of a membrane was higher than the control group, it was not 
significantly different (p>0.05).
Comparison between the treatment groups
In Fig. 4, the viability of human dental pulp cells (%) in the treatment 
group exposed to 2 mg RCSSS in the form of a membrane was higher 
than the viability of human dental pulp cells (%) in the other treatment 
groups. In addition, the viability of human dental pulp cells (%) in the 
treatment group that has been exposed to 1 mg RGD chitosan from [5] 
shrimp shell scaffold in the form of a membrane was lower than the 
treatment group that has been exposed to 1 mg CSSS in the form of a 
membrane, whereas the viability of human dental pulp cells (%) in 
the treatment group that has been exposed to 2 mg RCSSS in the form 
of a membrane was higher than the treatment group that has been 
exposed to 2 mg CSSS in the form of a membrane. Based on the one-way 
ANOVA test with post hoc (Tukey–Bonferonni), there was a significant 
difference between the viability of human dental pulp cells (%) in the 
treatment group exposed to 1 mg RCSSS in the form of a membrane and 
the treatment group exposed to 1 mg CSSS in the form of a membrane 
(p<0.05). Furthermore, there was also a significant difference between 
the viability of human dental pulp cells (%) in the treatment group 
exposed to 2 mg RCSSS in the form of a membrane and the treatment 
group exposed to 2 mg CSSS in the form of a membrane (p<0.05).
Furthermore, the viability of human dental pulp cells (%) in the 
treatment group exposed to 2 mg RCSSS in the form of a membrane 
was higher than the treatment group exposed to 1 mg CSSS in the 
form of a membrane. Based on the one-way ANOVA test with post hoc 
(Tukey–Bonferonni), there was a significant difference between the 
viability of human dental pulp cells (%) in the treatment group exposed 
to 2 mg RCSSS in the form of a membrane and the treatment group 
exposed to 1 mg RCSSS in the form of a membrane (p<0.01). However, 
the result showed that there was no significant difference between the 
viability of human dental pulp cells (%) in the treatment group exposed 
to 1 mg CSSS in the form of a membrane and the treatment group 
exposed to 2 mg CSSS in the form of a membrane.
DISCUSSION
Chitosan is a polymer that has been widely studied as a scaffold 
in bone tissue engineering because it has good biocompatibility 
and biodegradability properties and the capability to support cell 
proliferation. One of the most recent developments in chitosan scaffolds 
is to form chitosan as a membrane-shaped scaffold. Chitosan scaffolds 
in the shape of a membrane are expected to be able to act as a temporary 
bone that can adhere to and cover an anatomical area with a large defect, 
supporting localized cell proliferation and differentiation [16,17]. The 
cell proliferation and differentiation were primarily can be controlled 
by improving cell adhesion to scaffold [6,18]. One way to improve the 
cell adhesion with a chitosan scaffold is to combine the scaffold with 
Arg-Gly-Asp (RGD). According to the previous studies, adding RGD to a 
chitosan scaffold supported scaffold adhesion to tissue [11].
Currently, BATAN has been developing CSSS in the form of membranes 
and has combined these scaffolds with RGD. However, before 
these scaffolds can be used in tissue engineering, they need to be 
tested for biocompatibility. According to the ISO standard 10993, a 
biocompatibility test needs to be conducted to evaluate cell and tissue 
response to the biomaterial being tested [15]. In this study, a toxicity 
analysis of RCSSS in the form of a membrane manufactured by BATAN 
was performed to evaluate its toxic response when put in contact 
human dental pulp cells. The toxicity analysis in this study refers to 
the viability of human dental pulp cells (%) after being exposed to the 
test material, which was the RCSSS in the form of a membrane. In this 
study, human dental pulp cells were used because dental pulp contains 
a considerable number of stem cells, and its isolation process is fairly 
easy to perform [19]. Moreover, according to the previous studies, stem 
cells from dental pulp are considered to be the right candidate for bone 
regeneration because of their ability to proliferate and differentiate into 
osteoblasts in culture [10].
The human dental pulp cells used in this study were cultured in a α-MEM 
culture medium containing penicillin, streptomycin, amphotericin B, 
and FBS for 5 days. A cell culture had to be done in advance because 
to perform a toxicity analysis, the cells must in monolayer form, or 
reached a subconfluent state in the bottom of the well. In addition, on 
the 5th day, all cells in culture had reached the log phase. The test of 
the cell’s viability at the log-phase stage was performed to determine 
whether, after exposure to test material, the cells could continue 
proliferating or stopped, which would be characterized by a decrease 
in cell viability.
Based on the toxicity analysis conducted with the MTT assay method, 
the viability of human dental pulp cells in all treatment groups was 
higher than the control group. This condition showed that exposure to 
the test material did not decrease the viability of human dental pulp 
cells. This result was consistent with the previous studies that reported 
chitosan from shrimp shells also manufactured by BATAN improved 
the OD or absorbance value of macaque DPSCs cell culture based on 
MTT assay method [6]. This result was also consistent with other 
studies that combined a chitosan scaffold with RGD. In the previous 
studies, adding RGD to a chitosan scaffold was reported to increase 
the biocompatibility and cytocompatibility of the chitosan scaffold 
when placed with bone marrow cells. This result was also supported 
by other studies that indicated that modification of RGD on the surface 
of nanofiber chitosan could significantly improve fibroblast adhesion 
to the nanofiber chitosan itself [20]. Another study reported that RGD 
immobilization to a chitosan scaffold showed an even better ability Fig. 4: Comparison of the treatment group
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to support osteoblast growth in cultures [11,14]. From these studies, 
it can be concluded that combining a chitosan scaffold with RGD can 
improve cell growth, so the hypothesis states that RCSSS in the form 
of a membrane is not toxic to human dental pulp cells can be accepted.
In the present study, the effect of the exposure of RCSSS in the form 
of a membrane and CSSS in the form of a membrane, weighed 1 mg 
and 2 mg, respectively, to the viability of human dental pulp cells was 
also analyzed. This was performed to determine whether there are 
differences in the effect of exposure of RCSSS in the form of a membrane 
and CSSS in the form of a membrane without RGD to the viability of 
the human dental pulp cells; this was done to determine the relation 
between the weight used and its effect. The effect of exposure of 1 mg 
RCSSS in the form of a membrane to the viability of human dental pulp 
cells showed no greater and significant effect than exposure from the 
1 mg CSSS in the form of a membrane. However, increasing the weight of 
the RCSSS in the form of a membrane exposed to 2 mg showed a better 
viability with human dental pulp cells than 2 mg CSSS in the form of a 
membrane.
Furthermore, based on the analysis in this study, increasing the weight 
of the RCSSS in the form of a membrane from 1 mg to 2 mg showed an 
improvement in the viability of human dental pulp cells; meanwhile, 
increasing the weight of the CSSS in the form of a membrane without 
RGD from 1 mg to 2 mg did not show improvement in the viability of 
human dental pulp cells. Based on the previous studies, the difference 
here was probably caused by the RGD. RGD in the scaffold affects 
cell adhesion, which indirectly causes better cell proliferation and 
growth [11]. This was consistent with a previous study that used a 
chitosan scaffold with RGD immobilization. Based on that study, the 
chitosan scaffold with RGD immobilization was reported to be able 
to support the growth of osteoblasts better than a chitosan scaffold 
without RGD immobilization [11,14].
Based on the study conducted by Cykitta in 2016 (unpublished), a 
porosity test on RCSSS in the form of a membrane and CSSS in the form 
of a membrane that were both manufactured by BATAN showed that 
the pores in the RCSSS in the form of a membrane were bigger than the 
CSSS in the form of a membrane. The pore size probably provided better 
cell penetration into the RGD chitosan so that increasing the weight of 
the scaffold produced an even greater effect [4,21]. However, based 
on the analysis of human dental pulp cell proliferation conducted by 
Mariska in 2016 (unpublished) using an MTT assay, adding RCSSS in the 
form of a membrane did not affect the ability of the scaffold to improve 
the proliferation of human dental pulp cells. The difference in these 
results is likely from the difference in manner and time of exposure to 
the scaffold.
Based on the analysis, it can be concluded that there was a different 
effect between the exposure of RCSSS in the form of a membrane and 
CSSS in the form of a membrane to the viability of human dental pulp 
cells; here, RCSSS in the form of a membrane showed to have a greater 
effect. However, whether that difference was influenced by the weight 
or concentration still could not be explained. In addition, this study also 
cannot explain the relationship between the dose and the effect that 
occurred after exposure to the test material because this study only 
used two concentrations or weights.
CONCLUSION
RCSSS in the form of a membrane is not toxic to human dental pulp cells, 
and its effect on the viability of human dental cells is greater than the 
CSSS in the form of a membrane without RGD. This result is an initial 
step that can be used for more research to support the effectiveness of 
RCSSS in the form of a membrane manufactured by BATAN. Therefore, 
more tests are highly recommended.
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